When was MetGen founded?

MetGen was founded in 2008 and raised its 1st funding round 5 years after it was founded.

Where is MetGen located?

MetGen is headquartered in Kaarina, Finland.

Who is the current CEO of MetGen?

Alex Michine of MetGen. They have also founded 1 company.

How many employees does MetGen have?

As of Jul 31, 2026, the latest employee count at MetGen is 21.

Is MetGen a funded company?

MetGen is a funded company, having raised a total of $3.51M across 10 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Feb 11, 2013.

When was the latest funding round of MetGen?

MetGen's latest funding was a $***** Grant (prize money) round on Jan 01, 2024, with participation from 1 investor. Its primary sector is Chemicals Tech. Globally, the Chemicals Tech sector has seen $336M in funding in 2026 to date.

Where does MetGen rank among its competitors?

MetGen ranks 90th amongst 349 active competitors, of which 134 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of MetGen?

MetGen's top competitors include Ginkgo Bioworks, Syngenta and Spark Therapeutics. Among them, Antheia secured the most recent funding round in January, 2026.

MetGen - 2026 Company Profile, Team, Funding & Competitors

MetGen is a public company based in Kaarina (Finland), founded in 2008 by Alex Azhayev and Alex Michine. It operates as a Develops industrial enzymes for Lignocellulosic biomass. MetGen has raised $3.51M in funding from Ecolab and Sofinnova Partners. The company has 349 active competitors, including 134 funded and 78 that have exited. Its top competitors include companies like Ginkgo Bioworks, Syngenta and Spark Therapeutics.

Company Details

MetGen develops and produces genetically modified eco-friendly enzymes that break down lignin. MetGen’s enzymes are industrial, highly-active, natural catalysts that accelerate chemical reactions. The company claims the use of MetGen enzyme leads to energy saving during the pulping process in paper manufacturing, reduced costs and improved yield in production of bioethanol from cellulosic waste and purification of water from phenolic compounds and lignin.

Website: www.metgen.com/
Email ID: *****@metgen.com

Key Metrics

Founded Year

2008

Location

Kaarina, Finland

Stage

Public

Total Funding

$3.51M in 10 rounds

Latest Funding Round

Grant (prize money), Jan 01, 2024, $*****

Investors

Ecolab & 8 more

Ranked

90^th among 349 active competitors

Employee Count

21 as on Jul 31, 2026

Similar Companies

Ginkgo Bioworks & 194 more

Exit Details

Public

View MetGen's full profile

MetGen has raised a total funding of $3.51M over 10 rounds. Its first funding round was on Feb 11, 2013. Its latest funding round was a Grant (prize money) round on Jan 01, 2024 for $*****. 1 investor participated in its latest round. MetGen has 9 institutional investors.

Here is the list of recent funding rounds of MetGen:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 01, 2024	6879420	Grant (prize money)	5626395	6403289	4680383	1401238
May 01, 2021	9092537	Grant (prize money)	1219839	2619964	5723077	Europa
Feb 01, 2019	4995301	Grant (prize money)	7196332	3005572	4794863	Europa

Access funding benchmarks and valuations. Sign up today!

View details of MetGen's funding rounds and investors

The founders of MetGen are Alex Azhayev and Alex Michine. Alex Michine is the CEO of MetGen.

Here are the details of MetGen's key team members:

Alex Azhayev: Co-Founder of MetGen and founder of 1 other company.
Alex Michine: Co-Founder & CEO of MetGen and founder of 1 other company.

View details of MetGen's Founder profiles and Board Members

MetGen's employee count trend

MetGen has 21 employees as of Jul 26. Here is MetGen's employee count trend over the years:

Uncover MetGen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MetGen include Ginkgo Bioworks, Syngenta and Spark Therapeutics. Here is the list of Top 10 competitors of MetGen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ginkgo Bioworks 2008, Boston (United States), Public	Autonomous labs for biotechnology, empowering scientists to design the living world	$796M	Viking Global Investors, T. Rowe Price & 53 others	81/100
2nd	Syngenta 2000, Basel (Switzerland), Acquired	Developer of technologies and sustainable farming practices for farmers	-	Analah Ventures, Europa	75/100
3rd	Spark Therapeutics 2013, Philadelphia (United States), Acquired	Developer of gene therapy for rare diseases	$82.8M	Sofinnova Investments, Brookside Capital & 6 others	73/100
4th	Twist Bioscience 2013, San Francisco (United States), Public	Developer of a semiconductor-based DNA synthesis platform	$321M	Foresite Capital, Fidelity Investments & 39 others	72/100
5th	Beam Therapeutics 2017, Cambridge (United States), Public	Developer of gene therapy using CRISPR base editing to treat diseases	$222M	Redmile Group, Cormorant-asset & 16 others	70/100
6th	Passage Bio 2017, Philadelphia (United States), Public	Developer of gene therapies for CNS rare diseases	$226M	Access Biotechnology, Orbimed & 10 others	69/100
7th	Codexis 2002, Redwood City (United States), Public	Developer of high-performance enzymes for drug discovery	$111M	Vivo Capital, Malaysian Life Sciences Capital Fund ... & 12 others	68/100
8th	AskBio 2001, Durham (United States), Acquired	Developer of AAV technologies for treating genetic and complex disorders	$235M	Vida Ventures, TPG & 4 others	68/100
9th	CureVac 2000, Tubingen (Germany), Acquired	Developer of mRNA-based therapeutics against cancer and infectious diseases	$975M	Dievini, Gates & 16 others	67/100
10th	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
90th	MetGen 2008, Kaarina (Finland), Public	Develops industrial enzymes for Lignocellulosic biomass	$3.51M	EIC Fund, Sofinnova Partners & 7 others	44/100